Neovascular age‐related macular degeneration at treatment intervals of 14 weeks or greater.

MLA

Cornish, Elisa E., et al. “Neovascular Age‐related Macular Degeneration at Treatment Intervals of 14 Weeks or Greater.” Clinical & Experimental Ophthalmology, vol. 49, no. 6, Aug. 2021, pp. 570–78. EBSCOhost, https://doi.org/10.1111/ceo.13962.

APA

Cornish, E. E., Nguyen, V., Young, S., Fraser, B. S., Guymer, R., Squirrell, D., Barthelmes, D., & Gillies, M. C. (2021). Neovascular age‐related macular degeneration at treatment intervals of 14 weeks or greater. Clinical & Experimental Ophthalmology, 49(6), 570–578. https://doi.org/10.1111/ceo.13962

Chicago

Cornish, Elisa E., Vuong Nguyen, Stephanie Young, Bell, Samantha Fraser, Robyn Guymer, David Squirrell, Daniel Barthelmes, and Mark C. Gillies. 2021. “Neovascular Age‐related Macular Degeneration at Treatment Intervals of 14 Weeks or Greater.” Clinical & Experimental Ophthalmology 49 (6): 570–78. doi:10.1111/ceo.13962.